A Senate committee has turned what was primarily a Democrat campaign against high drug prices into a bipartisan concern and is also pulling FDA regulations into the discussion.
The Special Committee on Aging penned letters to four drug manufacturers – Valeant Pharmaceuticals International Inc. (Valeant letter), Turing Pharmaceuticals AG(Turing letter), Retrophin Inc. (
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?